Basic Information
LncRNA/CircRNA Name | LINC00052 |
Synonyms | NA |
Region | GRCh38_15:87576929-87579866 |
Ensemble | ENSG00000259527 |
Refseq | NR_026869 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | head and neck squamous cell carcinoma |
ICD-0-3 | C76.0 |
Methods | qPCR, Western blot, Luciferase reporter assay, RIP |
Sample | CAL2 7 cells, FaDu cells and SCC9 cells, SAS cells and HaCaT cells, The tumor tissues and adjacent nontumorous tissue |
Expression Pattern | up-regulated |
Function Description | LINC00052 was upregulated in HNSCC tumors. High expression of LINC00052 was associated with poor prognosis. Gain and loss of function studies revealed that LINC00052 promoted HNSCC cell proliferation, migration and invasion. MiR -608 was predicted as an interacting microRNA of LINC00052 via bioinformatics analysis and was further validated through luciferase reporter assay and RNA -binding protein immunoprecipitation assay. Moreover, we demonstrated that LINC00052 sponged miR -608 to regulate the expression of epidermal growth factor receptor (EGFR ), thereby promoting HNSCC progression in vitro and in vivo. |
Pubmed ID | 31639333 |
Year | 2019 |
Title | Long non-coding RNA LINC00052 regulates miR-608/EGFR axis to promote progression of head and neck squamous cell carcinoma |
External Links
Links for LINC00052 | GenBank HGNC NONCODE |
Links for head and neck squamous cell carcinoma | OMIM COSMIC |